Production (Stage)
Bright Minds Biosciences Inc.
DRUG
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.42M | -789.50K | -2.06M | -2.65M | -3.89M |
| Total Depreciation and Amortization | 58.20K | 55.90K | 53.80K | 53.40K | 53.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -335.50K | -611.00K | 616.90K | 912.80K | 871.90K |
| Change in Net Operating Assets | -224.90K | -484.30K | 26.60K | -232.30K | -359.90K |
| Cash from Operations | -2.92M | -1.83M | -1.37M | -1.92M | -3.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -94.30K | -91.70K | -89.90K | -87.60K | -87.10K |
| Issuance of Common Stock | 49.81M | 49.56M | 900.00K | 900.00K | 900.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.51M | 2.51M | 300.00 | 0.00 | 0.00 |
| Cash from Financing | 37.30M | 37.13M | 595.80K | 597.00K | 597.00K |
| Foreign Exchange rate Adjustments | 1.19M | 1.20M | 8.40K | -125.70K | -57.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.57M | 36.50M | -761.30K | -1.45M | -2.78M |